Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current research centers on modifying the underlying mechanisms of MSA. One avenue under investigation involves drug-based interventions to regulate the activit